Ignite Creation Date:
2025-12-24 @ 10:01 PM
Ignite Modification Date:
2026-01-02 @ 12:39 AM
Study NCT ID:
NCT00055432
Status:
TERMINATED
Last Update Posted:
2006-09-15
First Post:
2003-03-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer
Sponsor:
Organization: